nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—ABCG2—hematologic cancer	0.139	0.706	CbGaD
Pravastatin—ABCB1—hematologic cancer	0.058	0.294	CbGaD
Pravastatin—ABCB11—Daunorubicin—hematologic cancer	0.0231	0.0436	CbGbCtD
Pravastatin—SLCO1A2—Chlorambucil—hematologic cancer	0.0207	0.0391	CbGbCtD
Pravastatin—ABCG2—Clofarabine—hematologic cancer	0.0187	0.0354	CbGbCtD
Pravastatin—ABCC2—Daunorubicin—hematologic cancer	0.0121	0.0229	CbGbCtD
Pravastatin—ABCG2—Daunorubicin—hematologic cancer	0.011	0.0207	CbGbCtD
Pravastatin—SLC16A1—Methotrexate—hematologic cancer	0.0107	0.0203	CbGbCtD
Pravastatin—SLC22A8—Mercaptopurine—hematologic cancer	0.00987	0.0187	CbGbCtD
Pravastatin—ABCB11—Vinblastine—hematologic cancer	0.00981	0.0186	CbGbCtD
Pravastatin—ABCB11—Vincristine—hematologic cancer	0.00965	0.0182	CbGbCtD
Pravastatin—ABCG2—Teniposide—hematologic cancer	0.00953	0.018	CbGbCtD
Pravastatin—ABCG2—Cladribine—hematologic cancer	0.00913	0.0173	CbGbCtD
Pravastatin—ABCG2—Imatinib—hematologic cancer	0.0084	0.0159	CbGbCtD
Pravastatin—SLCO1A2—Prednisolone—hematologic cancer	0.00782	0.0148	CbGbCtD
Pravastatin—ABCG2—Nilotinib—hematologic cancer	0.00763	0.0144	CbGbCtD
Pravastatin—SLCO1A2—Prednisone—hematologic cancer	0.00738	0.014	CbGbCtD
Pravastatin—ABCB11—Dexamethasone—hematologic cancer	0.00727	0.0137	CbGbCtD
Pravastatin—CYP2C9—Bexarotene—hematologic cancer	0.00695	0.0131	CbGbCtD
Pravastatin—ABCG2—Dasatinib—hematologic cancer	0.00675	0.0128	CbGbCtD
Pravastatin—ABCB1—Lenalidomide—hematologic cancer	0.00674	0.0128	CbGbCtD
Pravastatin—ABCG2—Mitoxantrone—hematologic cancer	0.00666	0.0126	CbGbCtD
Pravastatin—SLCO1B1—Irinotecan—hematologic cancer	0.0066	0.0125	CbGbCtD
Pravastatin—CYP2C8—Bortezomib—hematologic cancer	0.00611	0.0115	CbGbCtD
Pravastatin—CYP3A5—Daunorubicin—hematologic cancer	0.00608	0.0115	CbGbCtD
Pravastatin—ABCB11—Doxorubicin—hematologic cancer	0.00603	0.0114	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—hematologic cancer	0.006	0.0113	CbGbCtD
Pravastatin—CYP2D6—Lomustine—hematologic cancer	0.00591	0.0112	CbGbCtD
Pravastatin—ABCC2—Irinotecan—hematologic cancer	0.0058	0.011	CbGbCtD
Pravastatin—CYP2C9—Idarubicin—hematologic cancer	0.00576	0.0109	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—hematologic cancer	0.00555	0.0105	CbGbCtD
Pravastatin—CYP3A5—Thalidomide—hematologic cancer	0.00553	0.0105	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—hematologic cancer	0.00528	0.00999	CbGbCtD
Pravastatin—CYP3A5—Teniposide—hematologic cancer	0.00528	0.00998	CbGbCtD
Pravastatin—CYP2D6—Idarubicin—hematologic cancer	0.00527	0.00996	CbGbCtD
Pravastatin—ABCG2—Irinotecan—hematologic cancer	0.00525	0.00992	CbGbCtD
Pravastatin—ABCC2—Vinblastine—hematologic cancer	0.00516	0.00976	CbGbCtD
Pravastatin—ABCC2—Vincristine—hematologic cancer	0.00507	0.00959	CbGbCtD
Pravastatin—CYP3A5—Ifosfamide—hematologic cancer	0.00487	0.00921	CbGbCtD
Pravastatin—ABCC2—Cisplatin—hematologic cancer	0.00473	0.00895	CbGbCtD
Pravastatin—CYP2C8—Ifosfamide—hematologic cancer	0.00468	0.00886	CbGbCtD
Pravastatin—CYP3A5—Imatinib—hematologic cancer	0.00465	0.0088	CbGbCtD
Pravastatin—ABCC2—Etoposide—hematologic cancer	0.00465	0.00879	CbGbCtD
Pravastatin—SLCO1A2—Dexamethasone—hematologic cancer	0.00461	0.00872	CbGbCtD
Pravastatin—ABCG2—Vincristine—hematologic cancer	0.00459	0.00867	CbGbCtD
Pravastatin—CYP2D6—Hydroxyurea—hematologic cancer	0.00448	0.00847	CbGbCtD
Pravastatin—ABCG2—Cisplatin—hematologic cancer	0.00428	0.00809	CbGbCtD
Pravastatin—CYP2C9—Bortezomib—hematologic cancer	0.00426	0.00805	CbGbCtD
Pravastatin—ABCG2—Etoposide—hematologic cancer	0.0042	0.00795	CbGbCtD
Pravastatin—CYP2C8—Nilotinib—hematologic cancer	0.00407	0.00769	CbGbCtD
Pravastatin—CYP3A4—Bexarotene—hematologic cancer	0.00404	0.00764	CbGbCtD
Pravastatin—ABCB1—Daunorubicin—hematologic cancer	0.00395	0.00748	CbGbCtD
Pravastatin—CYP2D6—Bortezomib—hematologic cancer	0.0039	0.00737	CbGbCtD
Pravastatin—ABCB1—Alitretinoin—hematologic cancer	0.00387	0.00732	CbGbCtD
Pravastatin—ABCC2—Dexamethasone—hematologic cancer	0.00382	0.00723	CbGbCtD
Pravastatin—CYP3A4—Busulfan—hematologic cancer	0.00376	0.0071	CbGbCtD
Pravastatin—CYP3A4—Lomustine—hematologic cancer	0.00376	0.0071	CbGbCtD
Pravastatin—CYP3A5—Dasatinib—hematologic cancer	0.00374	0.00707	CbGbCtD
Pravastatin—CYP2C9—Thalidomide—hematologic cancer	0.00371	0.00702	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—hematologic cancer	0.0037	0.007	CbGbCtD
Pravastatin—CYP2C9—Teniposide—hematologic cancer	0.00354	0.00669	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—hematologic cancer	0.0035	0.00661	CbGbCtD
Pravastatin—ABCG2—Dexamethasone—hematologic cancer	0.00346	0.00653	CbGbCtD
Pravastatin—CYP3A4—Thiotepa—hematologic cancer	0.00335	0.00633	CbGbCtD
Pravastatin—CYP2C9—Ifosfamide—hematologic cancer	0.00327	0.00618	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—hematologic cancer	0.00323	0.0061	CbGbCtD
Pravastatin—ABCC2—Doxorubicin—hematologic cancer	0.00317	0.00599	CbGbCtD
Pravastatin—CYP2C9—Imatinib—hematologic cancer	0.00312	0.0059	CbGbCtD
Pravastatin—ABCC2—Methotrexate—hematologic cancer	0.00307	0.00581	CbGbCtD
Pravastatin—ABCB1—Imatinib—hematologic cancer	0.00303	0.00573	CbGbCtD
Pravastatin—CYP3A5—Irinotecan—hematologic cancer	0.00291	0.0055	CbGbCtD
Pravastatin—ABCG2—Doxorubicin—hematologic cancer	0.00287	0.00542	CbGbCtD
Pravastatin—CYP2D6—Imatinib—hematologic cancer	0.00285	0.0054	CbGbCtD
Pravastatin—CYP2C9—Nilotinib—hematologic cancer	0.00284	0.00536	CbGbCtD
Pravastatin—ABCG2—Methotrexate—hematologic cancer	0.00278	0.00525	CbGbCtD
Pravastatin—ABCB1—Nilotinib—hematologic cancer	0.00275	0.0052	CbGbCtD
Pravastatin—ABCB1—Vinorelbine—hematologic cancer	0.00273	0.00516	CbGbCtD
Pravastatin—CYP3A4—Methoxsalen—hematologic cancer	0.0026	0.00492	CbGbCtD
Pravastatin—CYP2D6—Nilotinib—hematologic cancer	0.00259	0.0049	CbGbCtD
Pravastatin—CYP2D6—Vinorelbine—hematologic cancer	0.00257	0.00486	CbGbCtD
Pravastatin—CYP3A5—Vincristine—hematologic cancer	0.00254	0.0048	CbGbCtD
Pravastatin—CYP3A4—Bortezomib—hematologic cancer	0.00248	0.00468	CbGbCtD
Pravastatin—ABCB1—Dasatinib—hematologic cancer	0.00243	0.0046	CbGbCtD
Pravastatin—ABCB1—Mitoxantrone—hematologic cancer	0.0024	0.00454	CbGbCtD
Pravastatin—CYP3A4—Daunorubicin—hematologic cancer	0.00237	0.00448	CbGbCtD
Pravastatin—CYP3A5—Etoposide—hematologic cancer	0.00233	0.0044	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—hematologic cancer	0.00225	0.00425	CbGbCtD
Pravastatin—CYP2C8—Etoposide—hematologic cancer	0.00224	0.00423	CbGbCtD
Pravastatin—ABCB1—Betamethasone—hematologic cancer	0.00214	0.00405	CbGbCtD
Pravastatin—ABCB1—Gemcitabine—hematologic cancer	0.00212	0.00401	CbGbCtD
Pravastatin—ABCB1—Prednisolone—hematologic cancer	0.00211	0.004	CbGbCtD
Pravastatin—CYP3A4—Cytarabine—hematologic cancer	0.00209	0.00395	CbGbCtD
Pravastatin—CYP3A4—Teniposide—hematologic cancer	0.00206	0.00389	CbGbCtD
Pravastatin—Lovastatin—ITGAL—hematologic cancer	0.00206	0.451	CrCbGaD
Pravastatin—ABCB1—Prednisone—hematologic cancer	0.002	0.00377	CbGbCtD
Pravastatin—CYP3A5—Dexamethasone—hematologic cancer	0.00191	0.00362	CbGbCtD
Pravastatin—CYP3A4—Ifosfamide—hematologic cancer	0.0019	0.00359	CbGbCtD
Pravastatin—ABCB1—Irinotecan—hematologic cancer	0.00189	0.00358	CbGbCtD
Pravastatin—CYP2C8—Dexamethasone—hematologic cancer	0.00184	0.00348	CbGbCtD
Pravastatin—CYP3A4—Imatinib—hematologic cancer	0.00181	0.00343	CbGbCtD
Pravastatin—CYP3A4—Ruxolitinib—hematologic cancer	0.00171	0.00323	CbGbCtD
Pravastatin—ABCB1—Vinblastine—hematologic cancer	0.00168	0.00318	CbGbCtD
Pravastatin—ABCB1—Vincristine—hematologic cancer	0.00165	0.00313	CbGbCtD
Pravastatin—CYP3A4—Nilotinib—hematologic cancer	0.00165	0.00312	CbGbCtD
Pravastatin—CYP3A4—Vinorelbine—hematologic cancer	0.00164	0.00309	CbGbCtD
Pravastatin—CYP2C9—Cisplatin—hematologic cancer	0.00159	0.003	CbGbCtD
Pravastatin—CYP2D6—Vinblastine—hematologic cancer	0.00158	0.003	CbGbCtD
Pravastatin—ABCB1—Cisplatin—hematologic cancer	0.00154	0.00292	CbGbCtD
Pravastatin—ABCB1—Etoposide—hematologic cancer	0.00152	0.00287	CbGbCtD
Pravastatin—CYP3A4—Triamcinolone—hematologic cancer	0.0015	0.00283	CbGbCtD
Pravastatin—CYP3A4—Dasatinib—hematologic cancer	0.00146	0.00276	CbGbCtD
Pravastatin—CYP3A4—Mitoxantrone—hematologic cancer	0.00144	0.00272	CbGbCtD
Pravastatin—CYP2C9—Dexamethasone—hematologic cancer	0.00128	0.00243	CbGbCtD
Pravastatin—CYP3A4—Betamethasone—hematologic cancer	0.00128	0.00243	CbGbCtD
Pravastatin—CYP3A4—Prednisolone—hematologic cancer	0.00127	0.00239	CbGbCtD
Pravastatin—ABCB1—Dexamethasone—hematologic cancer	0.00125	0.00236	CbGbCtD
Pravastatin—CYP3A4—Prednisone—hematologic cancer	0.0012	0.00226	CbGbCtD
Pravastatin—CYP2D6—Dexamethasone—hematologic cancer	0.00117	0.00222	CbGbCtD
Pravastatin—CYP3A4—Irinotecan—hematologic cancer	0.00113	0.00214	CbGbCtD
Pravastatin—Lovastatin—HDAC2—hematologic cancer	0.00113	0.247	CrCbGaD
Pravastatin—ABCB1—Doxorubicin—hematologic cancer	0.00103	0.00195	CbGbCtD
Pravastatin—CYP3A4—Vinblastine—hematologic cancer	0.00101	0.00191	CbGbCtD
Pravastatin—ABCB1—Methotrexate—hematologic cancer	0.001	0.00189	CbGbCtD
Pravastatin—CYP3A4—Vincristine—hematologic cancer	0.000991	0.00187	CbGbCtD
Pravastatin—CYP2D6—Doxorubicin—hematologic cancer	0.000974	0.00184	CbGbCtD
Pravastatin—CYP3A4—Etoposide—hematologic cancer	0.000908	0.00172	CbGbCtD
Pravastatin—HMGCR—hematopoietic system—hematologic cancer	0.000902	0.0395	CbGeAlD
Pravastatin—SLC16A1—hematopoietic system—hematologic cancer	0.000888	0.0389	CbGeAlD
Pravastatin—SLCO1B3—lung—hematologic cancer	0.000868	0.038	CbGeAlD
Pravastatin—SLCO1B1—hematopoietic system—hematologic cancer	0.000864	0.0379	CbGeAlD
Pravastatin—SLCO2B1—hematopoietic system—hematologic cancer	0.000764	0.0335	CbGeAlD
Pravastatin—CYP3A4—Dexamethasone—hematologic cancer	0.000746	0.00141	CbGbCtD
Pravastatin—ABCB11—testis—hematologic cancer	0.000706	0.0309	CbGeAlD
Pravastatin—SLCO1A2—hematopoietic system—hematologic cancer	0.000703	0.0308	CbGeAlD
Pravastatin—HMGCR—gonad—hematologic cancer	0.000686	0.0301	CbGeAlD
Pravastatin—SLC16A1—gonad—hematologic cancer	0.000675	0.0296	CbGeAlD
Pravastatin—SLC22A8—hematopoietic system—hematologic cancer	0.000671	0.0294	CbGeAlD
Pravastatin—SLC22A7—testis—hematologic cancer	0.000637	0.0279	CbGeAlD
Pravastatin—CYP3A4—Doxorubicin—hematologic cancer	0.000619	0.00117	CbGbCtD
Pravastatin—HMGCR—blood—hematologic cancer	0.000598	0.0262	CbGeAlD
Pravastatin—HMGCR—bone marrow—hematologic cancer	0.000578	0.0253	CbGeAlD
Pravastatin—SLCO1B1—blood—hematologic cancer	0.000572	0.0251	CbGeAlD
Pravastatin—Simvastatin—UGT1A1—hematologic cancer	0.000562	0.123	CrCbGaD
Pravastatin—Lovastatin—UGT1A1—hematologic cancer	0.00055	0.121	CrCbGaD
Pravastatin—HMGCR—lung—hematologic cancer	0.000524	0.023	CbGeAlD
Pravastatin—SLC16A1—lung—hematologic cancer	0.000516	0.0226	CbGeAlD
Pravastatin—HMGCR—testis—hematologic cancer	0.000494	0.0217	CbGeAlD
Pravastatin—CYP2C8—hematopoietic system—hematologic cancer	0.000491	0.0215	CbGeAlD
Pravastatin—SLC16A1—testis—hematologic cancer	0.000487	0.0213	CbGeAlD
Pravastatin—SLC22A8—blood—hematologic cancer	0.000445	0.0195	CbGeAlD
Pravastatin—SLCO2B1—lung—hematologic cancer	0.000444	0.0194	CbGeAlD
Pravastatin—CYP3A5—hematopoietic system—hematologic cancer	0.000443	0.0194	CbGeAlD
Pravastatin—CYP2C9—hematopoietic system—hematologic cancer	0.000436	0.0191	CbGeAlD
Pravastatin—ABCC2—blood—hematologic cancer	0.000434	0.019	CbGeAlD
Pravastatin—SLCO2B1—testis—hematologic cancer	0.000419	0.0184	CbGeAlD
Pravastatin—SLCO1A2—lung—hematologic cancer	0.000408	0.0179	CbGeAlD
Pravastatin—SLCO1A2—testis—hematologic cancer	0.000385	0.0169	CbGeAlD
Pravastatin—ABCC2—testis—hematologic cancer	0.000359	0.0157	CbGeAlD
Pravastatin—HMGCR—lymph node—hematologic cancer	0.000358	0.0157	CbGeAlD
Pravastatin—SLC16A1—lymph node—hematologic cancer	0.000353	0.0155	CbGeAlD
Pravastatin—CYP3A4—hematopoietic system—hematologic cancer	0.000333	0.0146	CbGeAlD
Pravastatin—CYP2D6—hematopoietic system—hematologic cancer	0.000327	0.0144	CbGeAlD
Pravastatin—CYP2C8—blood—hematologic cancer	0.000326	0.0143	CbGeAlD
Pravastatin—ABCG2—blood—hematologic cancer	0.000316	0.0139	CbGeAlD
Pravastatin—ABCG2—bone marrow—hematologic cancer	0.000306	0.0134	CbGeAlD
Pravastatin—SLCO2B1—lymph node—hematologic cancer	0.000304	0.0133	CbGeAlD
Pravastatin—CYP3A5—blood—hematologic cancer	0.000294	0.0129	CbGeAlD
Pravastatin—CYP2C9—blood—hematologic cancer	0.000289	0.0127	CbGeAlD
Pravastatin—ABCG2—lung—hematologic cancer	0.000277	0.0122	CbGeAlD
Pravastatin—CYP2C8—testis—hematologic cancer	0.000269	0.0118	CbGeAlD
Pravastatin—ABCG2—testis—hematologic cancer	0.000262	0.0115	CbGeAlD
Pravastatin—ABCC2—lymph node—hematologic cancer	0.00026	0.0114	CbGeAlD
Pravastatin—CYP3A5—lung—hematologic cancer	0.000258	0.0113	CbGeAlD
Pravastatin—ABCB1—hematopoietic system—hematologic cancer	0.000236	0.0103	CbGeAlD
Pravastatin—CYP3A4—blood—hematologic cancer	0.00022	0.00966	CbGeAlD
Pravastatin—CYP2D6—blood—hematologic cancer	0.000217	0.00951	CbGeAlD
Pravastatin—ABCG2—lymph node—hematologic cancer	0.00019	0.00832	CbGeAlD
Pravastatin—CYP2D6—testis—hematologic cancer	0.000179	0.00786	CbGeAlD
Pravastatin—ABCB1—gonad—hematologic cancer	0.000179	0.00785	CbGeAlD
Pravastatin—ABCB1—blood—hematologic cancer	0.000156	0.00684	CbGeAlD
Pravastatin—ABCB1—bone marrow—hematologic cancer	0.000151	0.00662	CbGeAlD
Pravastatin—ABCB1—lung—hematologic cancer	0.000137	0.006	CbGeAlD
Pravastatin—Simvastatin—ABCB1—hematologic cancer	0.000132	0.0289	CrCbGaD
Pravastatin—ABCB1—testis—hematologic cancer	0.000129	0.00566	CbGeAlD
Pravastatin—Lovastatin—ABCB1—hematologic cancer	0.000129	0.0283	CrCbGaD
Pravastatin—ABCB1—lymph node—hematologic cancer	9.36e-05	0.0041	CbGeAlD
Pravastatin—Rhinitis—Doxorubicin—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Pravastatin—Hepatitis—Doxorubicin—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Pravastatin—Hypersensitivity—Prednisolone—hematologic cancer	1.91e-05	0.000106	CcSEcCtD
Pravastatin—Hypoaesthesia—Doxorubicin—hematologic cancer	1.91e-05	0.000106	CcSEcCtD
Pravastatin—Pharyngitis—Doxorubicin—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Pravastatin—Dyspepsia—Dexamethasone—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Pravastatin—Dyspepsia—Betamethasone—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Pravastatin—Urticaria—Triamcinolone—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Pravastatin—Asthenia—Etoposide—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Pravastatin—Body temperature increased—Triamcinolone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Pravastatin—Oedema—Prednisone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Pravastatin—Anaphylactic shock—Prednisone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Pravastatin—Decreased appetite—Betamethasone—hematologic cancer	1.88e-05	0.000104	CcSEcCtD
Pravastatin—Decreased appetite—Dexamethasone—hematologic cancer	1.88e-05	0.000104	CcSEcCtD
Pravastatin—Nausea—Irinotecan—hematologic cancer	1.88e-05	0.000104	CcSEcCtD
Pravastatin—Nausea—Mitoxantrone—hematologic cancer	1.88e-05	0.000104	CcSEcCtD
Pravastatin—Infection—Prednisone—hematologic cancer	1.87e-05	0.000104	CcSEcCtD
Pravastatin—Fatigue—Betamethasone—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Pravastatin—Fatigue—Dexamethasone—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Pravastatin—Chills—Epirubicin—hematologic cancer	1.86e-05	0.000103	CcSEcCtD
Pravastatin—Pruritus—Etoposide—hematologic cancer	1.86e-05	0.000103	CcSEcCtD
Pravastatin—Arrhythmia—Epirubicin—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Pravastatin—Pain—Dexamethasone—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Pravastatin—Pain—Betamethasone—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Pravastatin—Visual impairment—Doxorubicin—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Pravastatin—Alopecia—Epirubicin—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Pravastatin—Nausea—Gemcitabine—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Pravastatin—Vomiting—Cisplatin—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Pravastatin—Hyperhidrosis—Prednisone—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Pravastatin—Erythema multiforme—Doxorubicin—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Pravastatin—Rash—Cisplatin—hematologic cancer	1.81e-05	0.0001	CcSEcCtD
Pravastatin—Dermatitis—Cisplatin—hematologic cancer	1.81e-05	0.0001	CcSEcCtD
Pravastatin—Diarrhoea—Etoposide—hematologic cancer	1.8e-05	9.99e-05	CcSEcCtD
Pravastatin—Anorexia—Prednisone—hematologic cancer	1.79e-05	9.97e-05	CcSEcCtD
Pravastatin—Ill-defined disorder—Methotrexate—hematologic cancer	1.79e-05	9.94e-05	CcSEcCtD
Pravastatin—Tinnitus—Doxorubicin—hematologic cancer	1.79e-05	9.94e-05	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—hematologic cancer	1.78e-05	9.9e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Dexamethasone—hematologic cancer	1.78e-05	9.9e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Betamethasone—hematologic cancer	1.78e-05	9.9e-05	CcSEcCtD
Pravastatin—Cardiac disorder—Doxorubicin—hematologic cancer	1.78e-05	9.89e-05	CcSEcCtD
Pravastatin—Flushing—Doxorubicin—hematologic cancer	1.78e-05	9.89e-05	CcSEcCtD
Pravastatin—Flatulence—Epirubicin—hematologic cancer	1.78e-05	9.88e-05	CcSEcCtD
Pravastatin—Tension—Epirubicin—hematologic cancer	1.77e-05	9.84e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.77e-05	9.82e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.77e-05	9.82e-05	CcSEcCtD
Pravastatin—Dysgeusia—Epirubicin—hematologic cancer	1.77e-05	9.82e-05	CcSEcCtD
Pravastatin—Hypersensitivity—Triamcinolone—hematologic cancer	1.75e-05	9.76e-05	CcSEcCtD
Pravastatin—Nervousness—Epirubicin—hematologic cancer	1.75e-05	9.74e-05	CcSEcCtD
Pravastatin—Malaise—Methotrexate—hematologic cancer	1.74e-05	9.66e-05	CcSEcCtD
Pravastatin—Dizziness—Etoposide—hematologic cancer	1.74e-05	9.65e-05	CcSEcCtD
Pravastatin—Muscle spasms—Epirubicin—hematologic cancer	1.73e-05	9.64e-05	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—hematologic cancer	1.73e-05	9.63e-05	CcSEcCtD
Pravastatin—Leukopenia—Methotrexate—hematologic cancer	1.73e-05	9.59e-05	CcSEcCtD
Pravastatin—Chills—Doxorubicin—hematologic cancer	1.72e-05	9.56e-05	CcSEcCtD
Pravastatin—Urticaria—Betamethasone—hematologic cancer	1.72e-05	9.54e-05	CcSEcCtD
Pravastatin—Urticaria—Dexamethasone—hematologic cancer	1.72e-05	9.54e-05	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.71e-05	9.53e-05	CcSEcCtD
Pravastatin—Dizziness—Prednisolone—hematologic cancer	1.71e-05	9.52e-05	CcSEcCtD
Pravastatin—Arrhythmia—Doxorubicin—hematologic cancer	1.71e-05	9.52e-05	CcSEcCtD
Pravastatin—Asthenia—Triamcinolone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Pravastatin—Abdominal pain—Dexamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Pravastatin—Abdominal pain—Betamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Pravastatin—Body temperature increased—Betamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Pravastatin—Body temperature increased—Dexamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Pravastatin—Nausea—Cisplatin—hematologic cancer	1.7e-05	9.47e-05	CcSEcCtD
Pravastatin—Insomnia—Prednisone—hematologic cancer	1.7e-05	9.46e-05	CcSEcCtD
Pravastatin—Vision blurred—Epirubicin—hematologic cancer	1.7e-05	9.45e-05	CcSEcCtD
Pravastatin—Alopecia—Doxorubicin—hematologic cancer	1.69e-05	9.42e-05	CcSEcCtD
Pravastatin—Paraesthesia—Prednisone—hematologic cancer	1.69e-05	9.4e-05	CcSEcCtD
Pravastatin—Pruritus—Triamcinolone—hematologic cancer	1.69e-05	9.37e-05	CcSEcCtD
Pravastatin—Cough—Methotrexate—hematologic cancer	1.68e-05	9.35e-05	CcSEcCtD
Pravastatin—Ill-defined disorder—Epirubicin—hematologic cancer	1.67e-05	9.3e-05	CcSEcCtD
Pravastatin—Vomiting—Etoposide—hematologic cancer	1.67e-05	9.28e-05	CcSEcCtD
Pravastatin—Anaemia—Epirubicin—hematologic cancer	1.67e-05	9.27e-05	CcSEcCtD
Pravastatin—Dyspepsia—Prednisone—hematologic cancer	1.66e-05	9.21e-05	CcSEcCtD
Pravastatin—Rash—Etoposide—hematologic cancer	1.66e-05	9.2e-05	CcSEcCtD
Pravastatin—Dermatitis—Etoposide—hematologic cancer	1.65e-05	9.2e-05	CcSEcCtD
Pravastatin—Headache—Etoposide—hematologic cancer	1.65e-05	9.15e-05	CcSEcCtD
Pravastatin—Flatulence—Doxorubicin—hematologic cancer	1.64e-05	9.14e-05	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—hematologic cancer	1.64e-05	9.12e-05	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—hematologic cancer	1.64e-05	9.12e-05	CcSEcCtD
Pravastatin—Myalgia—Methotrexate—hematologic cancer	1.64e-05	9.12e-05	CcSEcCtD
Pravastatin—Tension—Doxorubicin—hematologic cancer	1.64e-05	9.1e-05	CcSEcCtD
Pravastatin—Decreased appetite—Prednisone—hematologic cancer	1.64e-05	9.1e-05	CcSEcCtD
Pravastatin—Dysgeusia—Doxorubicin—hematologic cancer	1.63e-05	9.09e-05	CcSEcCtD
Pravastatin—Rash—Prednisolone—hematologic cancer	1.63e-05	9.08e-05	CcSEcCtD
Pravastatin—Dermatitis—Prednisolone—hematologic cancer	1.63e-05	9.07e-05	CcSEcCtD
Pravastatin—Malaise—Epirubicin—hematologic cancer	1.63e-05	9.04e-05	CcSEcCtD
Pravastatin—Fatigue—Prednisone—hematologic cancer	1.62e-05	9.02e-05	CcSEcCtD
Pravastatin—Headache—Prednisolone—hematologic cancer	1.62e-05	9.02e-05	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—hematologic cancer	1.62e-05	9.01e-05	CcSEcCtD
Pravastatin—Nervousness—Doxorubicin—hematologic cancer	1.62e-05	9.01e-05	CcSEcCtD
Pravastatin—Vertigo—Epirubicin—hematologic cancer	1.62e-05	9.01e-05	CcSEcCtD
Pravastatin—Leukopenia—Epirubicin—hematologic cancer	1.61e-05	8.98e-05	CcSEcCtD
Pravastatin—Constipation—Prednisone—hematologic cancer	1.61e-05	8.95e-05	CcSEcCtD
Pravastatin—Muscle spasms—Doxorubicin—hematologic cancer	1.6e-05	8.92e-05	CcSEcCtD
Pravastatin—Confusional state—Methotrexate—hematologic cancer	1.59e-05	8.82e-05	CcSEcCtD
Pravastatin—Dizziness—Triamcinolone—hematologic cancer	1.58e-05	8.76e-05	CcSEcCtD
Pravastatin—Cough—Epirubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—hematologic cancer	1.57e-05	8.74e-05	CcSEcCtD
Pravastatin—Vision blurred—Doxorubicin—hematologic cancer	1.57e-05	8.74e-05	CcSEcCtD
Pravastatin—Infection—Methotrexate—hematologic cancer	1.56e-05	8.69e-05	CcSEcCtD
Pravastatin—Nausea—Etoposide—hematologic cancer	1.56e-05	8.67e-05	CcSEcCtD
Pravastatin—Hypertension—Epirubicin—hematologic cancer	1.56e-05	8.66e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Prednisone—hematologic cancer	1.55e-05	8.62e-05	CcSEcCtD
Pravastatin—Asthenia—Dexamethasone—hematologic cancer	1.55e-05	8.62e-05	CcSEcCtD
Pravastatin—Asthenia—Betamethasone—hematologic cancer	1.55e-05	8.62e-05	CcSEcCtD
Pravastatin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.55e-05	8.61e-05	CcSEcCtD
Pravastatin—Anaemia—Doxorubicin—hematologic cancer	1.54e-05	8.57e-05	CcSEcCtD
Pravastatin—Thrombocytopenia—Methotrexate—hematologic cancer	1.54e-05	8.56e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Prednisone—hematologic cancer	1.54e-05	8.56e-05	CcSEcCtD
Pravastatin—Nausea—Prednisolone—hematologic cancer	1.54e-05	8.55e-05	CcSEcCtD
Pravastatin—Arthralgia—Epirubicin—hematologic cancer	1.54e-05	8.54e-05	CcSEcCtD
Pravastatin—Chest pain—Epirubicin—hematologic cancer	1.54e-05	8.54e-05	CcSEcCtD
Pravastatin—Myalgia—Epirubicin—hematologic cancer	1.54e-05	8.54e-05	CcSEcCtD
Pravastatin—Anxiety—Epirubicin—hematologic cancer	1.53e-05	8.51e-05	CcSEcCtD
Pravastatin—Pruritus—Dexamethasone—hematologic cancer	1.53e-05	8.5e-05	CcSEcCtD
Pravastatin—Pruritus—Betamethasone—hematologic cancer	1.53e-05	8.5e-05	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—hematologic cancer	1.52e-05	8.45e-05	CcSEcCtD
Pravastatin—Discomfort—Epirubicin—hematologic cancer	1.52e-05	8.43e-05	CcSEcCtD
Pravastatin—Vomiting—Triamcinolone—hematologic cancer	1.51e-05	8.42e-05	CcSEcCtD
Pravastatin—Malaise—Doxorubicin—hematologic cancer	1.5e-05	8.37e-05	CcSEcCtD
Pravastatin—Rash—Triamcinolone—hematologic cancer	1.5e-05	8.35e-05	CcSEcCtD
Pravastatin—Dermatitis—Triamcinolone—hematologic cancer	1.5e-05	8.34e-05	CcSEcCtD
Pravastatin—Vertigo—Doxorubicin—hematologic cancer	1.5e-05	8.34e-05	CcSEcCtD
Pravastatin—Anorexia—Methotrexate—hematologic cancer	1.5e-05	8.34e-05	CcSEcCtD
Pravastatin—Urticaria—Prednisone—hematologic cancer	1.5e-05	8.31e-05	CcSEcCtD
Pravastatin—Leukopenia—Doxorubicin—hematologic cancer	1.49e-05	8.3e-05	CcSEcCtD
Pravastatin—Headache—Triamcinolone—hematologic cancer	1.49e-05	8.3e-05	CcSEcCtD
Pravastatin—Body temperature increased—Prednisone—hematologic cancer	1.49e-05	8.27e-05	CcSEcCtD
Pravastatin—Abdominal pain—Prednisone—hematologic cancer	1.49e-05	8.27e-05	CcSEcCtD
Pravastatin—Confusional state—Epirubicin—hematologic cancer	1.48e-05	8.25e-05	CcSEcCtD
Pravastatin—Diarrhoea—Dexamethasone—hematologic cancer	1.48e-05	8.22e-05	CcSEcCtD
Pravastatin—Diarrhoea—Betamethasone—hematologic cancer	1.48e-05	8.22e-05	CcSEcCtD
Pravastatin—Anaphylactic shock—Epirubicin—hematologic cancer	1.47e-05	8.18e-05	CcSEcCtD
Pravastatin—Oedema—Epirubicin—hematologic cancer	1.47e-05	8.18e-05	CcSEcCtD
Pravastatin—Infection—Epirubicin—hematologic cancer	1.46e-05	8.13e-05	CcSEcCtD
Pravastatin—Cough—Doxorubicin—hematologic cancer	1.46e-05	8.1e-05	CcSEcCtD
Pravastatin—Thrombocytopenia—Epirubicin—hematologic cancer	1.44e-05	8.01e-05	CcSEcCtD
Pravastatin—Hypertension—Doxorubicin—hematologic cancer	1.44e-05	8.01e-05	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.43e-05	7.97e-05	CcSEcCtD
Pravastatin—Dizziness—Dexamethasone—hematologic cancer	1.43e-05	7.94e-05	CcSEcCtD
Pravastatin—Dizziness—Betamethasone—hematologic cancer	1.43e-05	7.94e-05	CcSEcCtD
Pravastatin—Hyperhidrosis—Epirubicin—hematologic cancer	1.42e-05	7.91e-05	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—hematologic cancer	1.42e-05	7.91e-05	CcSEcCtD
Pravastatin—Myalgia—Doxorubicin—hematologic cancer	1.42e-05	7.9e-05	CcSEcCtD
Pravastatin—Chest pain—Doxorubicin—hematologic cancer	1.42e-05	7.9e-05	CcSEcCtD
Pravastatin—Arthralgia—Doxorubicin—hematologic cancer	1.42e-05	7.9e-05	CcSEcCtD
Pravastatin—Anxiety—Doxorubicin—hematologic cancer	1.42e-05	7.87e-05	CcSEcCtD
Pravastatin—Nausea—Triamcinolone—hematologic cancer	1.41e-05	7.87e-05	CcSEcCtD
Pravastatin—Paraesthesia—Methotrexate—hematologic cancer	1.41e-05	7.85e-05	CcSEcCtD
Pravastatin—Discomfort—Doxorubicin—hematologic cancer	1.4e-05	7.8e-05	CcSEcCtD
Pravastatin—Anorexia—Epirubicin—hematologic cancer	1.4e-05	7.8e-05	CcSEcCtD
Pravastatin—Dyspnoea—Methotrexate—hematologic cancer	1.4e-05	7.8e-05	CcSEcCtD
Pravastatin—Hypersensitivity—Prednisone—hematologic cancer	1.39e-05	7.71e-05	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—hematologic cancer	1.38e-05	7.7e-05	CcSEcCtD
Pravastatin—Vomiting—Betamethasone—hematologic cancer	1.37e-05	7.64e-05	CcSEcCtD
Pravastatin—Vomiting—Dexamethasone—hematologic cancer	1.37e-05	7.64e-05	CcSEcCtD
Pravastatin—Confusional state—Doxorubicin—hematologic cancer	1.37e-05	7.63e-05	CcSEcCtD
Pravastatin—Decreased appetite—Methotrexate—hematologic cancer	1.37e-05	7.6e-05	CcSEcCtD
Pravastatin—Rash—Dexamethasone—hematologic cancer	1.36e-05	7.58e-05	CcSEcCtD
Pravastatin—Rash—Betamethasone—hematologic cancer	1.36e-05	7.58e-05	CcSEcCtD
Pravastatin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.36e-05	7.57e-05	CcSEcCtD
Pravastatin—Oedema—Doxorubicin—hematologic cancer	1.36e-05	7.57e-05	CcSEcCtD
Pravastatin—Dermatitis—Betamethasone—hematologic cancer	1.36e-05	7.57e-05	CcSEcCtD
Pravastatin—Dermatitis—Dexamethasone—hematologic cancer	1.36e-05	7.57e-05	CcSEcCtD
Pravastatin—Fatigue—Methotrexate—hematologic cancer	1.36e-05	7.54e-05	CcSEcCtD
Pravastatin—Headache—Betamethasone—hematologic cancer	1.35e-05	7.53e-05	CcSEcCtD
Pravastatin—Headache—Dexamethasone—hematologic cancer	1.35e-05	7.53e-05	CcSEcCtD
Pravastatin—Infection—Doxorubicin—hematologic cancer	1.35e-05	7.52e-05	CcSEcCtD
Pravastatin—Asthenia—Prednisone—hematologic cancer	1.35e-05	7.51e-05	CcSEcCtD
Pravastatin—Pain—Methotrexate—hematologic cancer	1.35e-05	7.48e-05	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.34e-05	7.46e-05	CcSEcCtD
Pravastatin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.33e-05	7.41e-05	CcSEcCtD
Pravastatin—Pruritus—Prednisone—hematologic cancer	1.33e-05	7.4e-05	CcSEcCtD
Pravastatin—Insomnia—Epirubicin—hematologic cancer	1.33e-05	7.4e-05	CcSEcCtD
Pravastatin—Paraesthesia—Epirubicin—hematologic cancer	1.32e-05	7.35e-05	CcSEcCtD
Pravastatin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.32e-05	7.32e-05	CcSEcCtD
Pravastatin—Dyspnoea—Epirubicin—hematologic cancer	1.31e-05	7.3e-05	CcSEcCtD
Pravastatin—Anorexia—Doxorubicin—hematologic cancer	1.3e-05	7.22e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Methotrexate—hematologic cancer	1.3e-05	7.21e-05	CcSEcCtD
Pravastatin—Dyspepsia—Epirubicin—hematologic cancer	1.3e-05	7.2e-05	CcSEcCtD
Pravastatin—Diarrhoea—Prednisone—hematologic cancer	1.29e-05	7.16e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.29e-05	7.15e-05	CcSEcCtD
Pravastatin—Nausea—Dexamethasone—hematologic cancer	1.28e-05	7.14e-05	CcSEcCtD
Pravastatin—Nausea—Betamethasone—hematologic cancer	1.28e-05	7.14e-05	CcSEcCtD
Pravastatin—Decreased appetite—Epirubicin—hematologic cancer	1.28e-05	7.11e-05	CcSEcCtD
Pravastatin—Fatigue—Epirubicin—hematologic cancer	1.27e-05	7.06e-05	CcSEcCtD
Pravastatin—Pain—Epirubicin—hematologic cancer	1.26e-05	7e-05	CcSEcCtD
Pravastatin—Constipation—Epirubicin—hematologic cancer	1.26e-05	7e-05	CcSEcCtD
Pravastatin—Urticaria—Methotrexate—hematologic cancer	1.25e-05	6.95e-05	CcSEcCtD
Pravastatin—Dizziness—Prednisone—hematologic cancer	1.24e-05	6.92e-05	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—hematologic cancer	1.24e-05	6.91e-05	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—hematologic cancer	1.24e-05	6.91e-05	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.24e-05	6.9e-05	CcSEcCtD
Pravastatin—Insomnia—Doxorubicin—hematologic cancer	1.23e-05	6.85e-05	CcSEcCtD
Pravastatin—Paraesthesia—Doxorubicin—hematologic cancer	1.22e-05	6.8e-05	CcSEcCtD
Pravastatin—Dyspnoea—Doxorubicin—hematologic cancer	1.21e-05	6.75e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Epirubicin—hematologic cancer	1.21e-05	6.74e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.2e-05	6.69e-05	CcSEcCtD
Pravastatin—Dyspepsia—Doxorubicin—hematologic cancer	1.2e-05	6.67e-05	CcSEcCtD
Pravastatin—Vomiting—Prednisone—hematologic cancer	1.2e-05	6.65e-05	CcSEcCtD
Pravastatin—Rash—Prednisone—hematologic cancer	1.19e-05	6.6e-05	CcSEcCtD
Pravastatin—Dermatitis—Prednisone—hematologic cancer	1.19e-05	6.59e-05	CcSEcCtD
Pravastatin—Decreased appetite—Doxorubicin—hematologic cancer	1.18e-05	6.58e-05	CcSEcCtD
Pravastatin—Headache—Prednisone—hematologic cancer	1.18e-05	6.55e-05	CcSEcCtD
Pravastatin—Fatigue—Doxorubicin—hematologic cancer	1.17e-05	6.53e-05	CcSEcCtD
Pravastatin—Urticaria—Epirubicin—hematologic cancer	1.17e-05	6.5e-05	CcSEcCtD
Pravastatin—Pain—Doxorubicin—hematologic cancer	1.16e-05	6.47e-05	CcSEcCtD
Pravastatin—Constipation—Doxorubicin—hematologic cancer	1.16e-05	6.47e-05	CcSEcCtD
Pravastatin—Abdominal pain—Epirubicin—hematologic cancer	1.16e-05	6.47e-05	CcSEcCtD
Pravastatin—Body temperature increased—Epirubicin—hematologic cancer	1.16e-05	6.47e-05	CcSEcCtD
Pravastatin—Hypersensitivity—Methotrexate—hematologic cancer	1.16e-05	6.44e-05	CcSEcCtD
Pravastatin—Asthenia—Methotrexate—hematologic cancer	1.13e-05	6.27e-05	CcSEcCtD
Pravastatin—Feeling abnormal—Doxorubicin—hematologic cancer	1.12e-05	6.24e-05	CcSEcCtD
Pravastatin—Nausea—Prednisone—hematologic cancer	1.12e-05	6.21e-05	CcSEcCtD
Pravastatin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.11e-05	6.19e-05	CcSEcCtD
Pravastatin—Pruritus—Methotrexate—hematologic cancer	1.11e-05	6.19e-05	CcSEcCtD
Pravastatin—Hypersensitivity—Epirubicin—hematologic cancer	1.08e-05	6.03e-05	CcSEcCtD
Pravastatin—Urticaria—Doxorubicin—hematologic cancer	1.08e-05	6.02e-05	CcSEcCtD
Pravastatin—Abdominal pain—Doxorubicin—hematologic cancer	1.08e-05	5.99e-05	CcSEcCtD
Pravastatin—Body temperature increased—Doxorubicin—hematologic cancer	1.08e-05	5.99e-05	CcSEcCtD
Pravastatin—Diarrhoea—Methotrexate—hematologic cancer	1.08e-05	5.98e-05	CcSEcCtD
Pravastatin—Asthenia—Epirubicin—hematologic cancer	1.06e-05	5.87e-05	CcSEcCtD
Pravastatin—Pruritus—Epirubicin—hematologic cancer	1.04e-05	5.79e-05	CcSEcCtD
Pravastatin—Dizziness—Methotrexate—hematologic cancer	1.04e-05	5.78e-05	CcSEcCtD
Pravastatin—Diarrhoea—Epirubicin—hematologic cancer	1.01e-05	5.6e-05	CcSEcCtD
Pravastatin—Hypersensitivity—Doxorubicin—hematologic cancer	1e-05	5.58e-05	CcSEcCtD
Pravastatin—Vomiting—Methotrexate—hematologic cancer	1e-05	5.56e-05	CcSEcCtD
Pravastatin—Rash—Methotrexate—hematologic cancer	9.92e-06	5.51e-05	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—hematologic cancer	9.91e-06	5.51e-05	CcSEcCtD
Pravastatin—Headache—Methotrexate—hematologic cancer	9.85e-06	5.48e-05	CcSEcCtD
Pravastatin—Asthenia—Doxorubicin—hematologic cancer	9.77e-06	5.43e-05	CcSEcCtD
Pravastatin—Dizziness—Epirubicin—hematologic cancer	9.73e-06	5.41e-05	CcSEcCtD
Pravastatin—Pruritus—Doxorubicin—hematologic cancer	9.64e-06	5.36e-05	CcSEcCtD
Pravastatin—Vomiting—Epirubicin—hematologic cancer	9.36e-06	5.2e-05	CcSEcCtD
Pravastatin—Nausea—Methotrexate—hematologic cancer	9.34e-06	5.19e-05	CcSEcCtD
Pravastatin—Diarrhoea—Doxorubicin—hematologic cancer	9.32e-06	5.18e-05	CcSEcCtD
Pravastatin—Rash—Epirubicin—hematologic cancer	9.28e-06	5.16e-05	CcSEcCtD
Pravastatin—Dermatitis—Epirubicin—hematologic cancer	9.27e-06	5.15e-05	CcSEcCtD
Pravastatin—Headache—Epirubicin—hematologic cancer	9.22e-06	5.13e-05	CcSEcCtD
Pravastatin—Dizziness—Doxorubicin—hematologic cancer	9.01e-06	5.01e-05	CcSEcCtD
Pravastatin—Nausea—Epirubicin—hematologic cancer	8.74e-06	4.86e-05	CcSEcCtD
Pravastatin—Vomiting—Doxorubicin—hematologic cancer	8.66e-06	4.81e-05	CcSEcCtD
Pravastatin—Rash—Doxorubicin—hematologic cancer	8.59e-06	4.77e-05	CcSEcCtD
Pravastatin—Dermatitis—Doxorubicin—hematologic cancer	8.58e-06	4.77e-05	CcSEcCtD
Pravastatin—Headache—Doxorubicin—hematologic cancer	8.53e-06	4.74e-05	CcSEcCtD
Pravastatin—Nausea—Doxorubicin—hematologic cancer	8.09e-06	4.5e-05	CcSEcCtD
Pravastatin—ABCB1—Metabolism—ALOX5—hematologic cancer	3.52e-06	5.3e-05	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	3.52e-06	5.3e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ALB—hematologic cancer	3.52e-06	5.3e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTT1—hematologic cancer	3.51e-06	5.29e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—UGT1A1—hematologic cancer	3.5e-06	5.27e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	3.47e-06	5.22e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.46e-06	5.21e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—MTAP—hematologic cancer	3.45e-06	5.2e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—MTHFR—hematologic cancer	3.44e-06	5.18e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—SDC1—hematologic cancer	3.43e-06	5.17e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NUP98—hematologic cancer	3.41e-06	5.13e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.4e-06	5.13e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.4e-06	5.13e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	3.38e-06	5.09e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.37e-06	5.08e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	3.37e-06	5.08e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CD44—hematologic cancer	3.37e-06	5.08e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NQO1—hematologic cancer	3.37e-06	5.08e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PIK3R1—hematologic cancer	3.36e-06	5.07e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.32e-06	4.99e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NCOA3—hematologic cancer	3.31e-06	4.98e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ADCY7—hematologic cancer	3.31e-06	4.98e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	3.3e-06	4.97e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.29e-06	4.95e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NUP214—hematologic cancer	3.29e-06	4.95e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.28e-06	4.94e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTEN—hematologic cancer	3.24e-06	4.88e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.24e-06	4.88e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—MTR—hematologic cancer	3.22e-06	4.85e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ABCG2—hematologic cancer	3.22e-06	4.85e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NUP98—hematologic cancer	3.21e-06	4.84e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYCS—hematologic cancer	3.19e-06	4.81e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—MTHFR—hematologic cancer	3.19e-06	4.8e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NUP98—hematologic cancer	3.18e-06	4.8e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.17e-06	4.77e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ENO2—hematologic cancer	3.16e-06	4.75e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CREBBP—hematologic cancer	3.14e-06	4.72e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.12e-06	4.7e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.12e-06	4.7e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PIK3CB—hematologic cancer	3.1e-06	4.68e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.1e-06	4.67e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NUP214—hematologic cancer	3.1e-06	4.66e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—EP300—hematologic cancer	3.09e-06	4.66e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.09e-06	4.66e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.09e-06	4.66e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—FHL2—hematologic cancer	3.08e-06	4.63e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NUP214—hematologic cancer	3.07e-06	4.62e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTT1—hematologic cancer	3.06e-06	4.61e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.04e-06	4.57e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.03e-06	4.57e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.03e-06	4.57e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—MTR—hematologic cancer	3.03e-06	4.57e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—AGRN—hematologic cancer	3.02e-06	4.55e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—MTR—hematologic cancer	3.01e-06	4.53e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.01e-06	4.53e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—SDC1—hematologic cancer	2.99e-06	4.51e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ENO2—hematologic cancer	2.97e-06	4.48e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	2.97e-06	4.48e-05	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.97e-06	4.47e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ENO2—hematologic cancer	2.95e-06	4.44e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ALB—hematologic cancer	2.94e-06	4.42e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CD44—hematologic cancer	2.92e-06	4.4e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NQO1—hematologic cancer	2.92e-06	4.4e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	2.89e-06	4.36e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTT1—hematologic cancer	2.88e-06	4.34e-05	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.87e-06	4.32e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—IDH2—hematologic cancer	2.86e-06	4.31e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HMMR—hematologic cancer	2.86e-06	4.31e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTT1—hematologic cancer	2.86e-06	4.31e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.86e-06	4.31e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTEN—hematologic cancer	2.85e-06	4.29e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SDC1—hematologic cancer	2.82e-06	4.25e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.82e-06	4.24e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTP1—hematologic cancer	2.81e-06	4.24e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	2.81e-06	4.23e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SDC1—hematologic cancer	2.8e-06	4.21e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYCS—hematologic cancer	2.76e-06	4.16e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	2.75e-06	4.14e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—EP300—hematologic cancer	2.72e-06	4.09e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.69e-06	4.05e-05	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.68e-06	4.04e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTEN—hematologic cancer	2.68e-06	4.04e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.68e-06	4.04e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CG—hematologic cancer	2.68e-06	4.03e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.67e-06	4.02e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ABCB1—hematologic cancer	2.66e-06	4.01e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.64e-06	3.97e-05	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PIK3CA—hematologic cancer	2.62e-06	3.94e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CA9—hematologic cancer	2.62e-06	3.94e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ACP5—hematologic cancer	2.62e-06	3.94e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.59e-06	3.9e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.58e-06	3.89e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.58e-06	3.89e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.58e-06	3.89e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—EP300—hematologic cancer	2.56e-06	3.85e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CD44—hematologic cancer	2.54e-06	3.83e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NQO1—hematologic cancer	2.54e-06	3.83e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.54e-06	3.83e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.52e-06	3.8e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ALB—hematologic cancer	2.51e-06	3.78e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CREBBP—hematologic cancer	2.48e-06	3.74e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.47e-06	3.72e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—IDH1—hematologic cancer	2.46e-06	3.71e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.44e-06	3.67e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.43e-06	3.66e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TXN—hematologic cancer	2.43e-06	3.66e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.43e-06	3.66e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYCS—hematologic cancer	2.41e-06	3.63e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.4e-06	3.62e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CD44—hematologic cancer	2.4e-06	3.61e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NQO1—hematologic cancer	2.4e-06	3.61e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.39e-06	3.6e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.38e-06	3.59e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NQO1—hematologic cancer	2.38e-06	3.58e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CD44—hematologic cancer	2.38e-06	3.58e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.36e-06	3.55e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.35e-06	3.55e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.33e-06	3.51e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ALB—hematologic cancer	2.32e-06	3.5e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.31e-06	3.47e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PIK3CA—hematologic cancer	2.29e-06	3.45e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.29e-06	3.44e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.28e-06	3.44e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYCS—hematologic cancer	2.27e-06	3.42e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.25e-06	3.4e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYCS—hematologic cancer	2.25e-06	3.39e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.24e-06	3.37e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.24e-06	3.37e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.24e-06	3.37e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.23e-06	3.37e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.22e-06	3.35e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.22e-06	3.35e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.22e-06	3.35e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.22e-06	3.34e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.17e-06	3.27e-05	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—AKT1—hematologic cancer	2.14e-06	3.22e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—EP300—hematologic cancer	2.14e-06	3.22e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTP1—hematologic cancer	2.12e-06	3.2e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.1e-06	3.16e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.05e-06	3.09e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.04e-06	3.07e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.04e-06	3.07e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.02e-06	3.05e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.01e-06	3.03e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.01e-06	3.03e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTP1—hematologic cancer	2e-06	3.01e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—MTR—hematologic cancer	1.98e-06	2.99e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.98e-06	2.99e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.98e-06	2.99e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.98e-06	2.98e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NCOR1—hematologic cancer	1.95e-06	2.94e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTM1—hematologic cancer	1.95e-06	2.94e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ENO2—hematologic cancer	1.94e-06	2.93e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.92e-06	2.89e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.92e-06	2.89e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.92e-06	2.88e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.89e-06	2.85e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.89e-06	2.85e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.89e-06	2.84e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.88e-06	2.83e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—AKT1—hematologic cancer	1.87e-06	2.82e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SDC1—hematologic cancer	1.84e-06	2.78e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.84e-06	2.77e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.84e-06	2.77e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—EP300—hematologic cancer	1.83e-06	2.75e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.82e-06	2.74e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.82e-06	2.74e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.78e-06	2.68e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTEN—hematologic cancer	1.77e-06	2.67e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.74e-06	2.63e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—MTHFR—hematologic cancer	1.72e-06	2.6e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—EP300—hematologic cancer	1.69e-06	2.55e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.69e-06	2.54e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ALB—hematologic cancer	1.67e-06	2.51e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.66e-06	2.5e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.64e-06	2.47e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.62e-06	2.45e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.61e-06	2.42e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.59e-06	2.4e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.58e-06	2.38e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NQO1—hematologic cancer	1.57e-06	2.36e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CD44—hematologic cancer	1.57e-06	2.36e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—AKT1—hematologic cancer	1.55e-06	2.33e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.54e-06	2.32e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.48e-06	2.23e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.47e-06	2.22e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.47e-06	2.21e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.46e-06	2.2e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.45e-06	2.18e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ALB—hematologic cancer	1.44e-06	2.17e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.42e-06	2.14e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.38e-06	2.08e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.36e-06	2.06e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.35e-06	2.04e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.35e-06	2.03e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CREBBP—hematologic cancer	1.34e-06	2.02e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.31e-06	1.97e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.29e-06	1.94e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.27e-06	1.92e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.27e-06	1.92e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTEN—hematologic cancer	1.27e-06	1.91e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.26e-06	1.91e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ALB—hematologic cancer	1.26e-06	1.89e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.25e-06	1.89e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.88e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.24e-06	1.86e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—EP300—hematologic cancer	1.21e-06	1.82e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.2e-06	1.81e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.2e-06	1.81e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.2e-06	1.81e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.2e-06	1.81e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.19e-06	1.79e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ALB—hematologic cancer	1.18e-06	1.78e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ALB—hematologic cancer	1.17e-06	1.77e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.13e-06	1.71e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.12e-06	1.69e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.11e-06	1.67e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.1e-06	1.66e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTEN—hematologic cancer	1.1e-06	1.66e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.06e-06	1.6e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—EP300—hematologic cancer	1.05e-06	1.58e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.05e-06	1.57e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.04e-06	1.56e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—AKT1—hematologic cancer	1.02e-06	1.54e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTEN—hematologic cancer	9.59e-07	1.44e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—EP300—hematologic cancer	9.14e-07	1.38e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTEN—hematologic cancer	9.03e-07	1.36e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	8.96e-07	1.35e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTEN—hematologic cancer	8.96e-07	1.35e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	8.92e-07	1.34e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—EP300—hematologic cancer	8.62e-07	1.3e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—EP300—hematologic cancer	8.54e-07	1.29e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.27e-07	1.25e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.84e-07	1.18e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	7.76e-07	1.17e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ALB—hematologic cancer	7.74e-07	1.17e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.4e-07	1.12e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—AKT1—hematologic cancer	7.32e-07	1.1e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.84e-07	1.03e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CA—hematologic cancer	6.76e-07	1.02e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.37e-07	9.6e-06	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—AKT1—hematologic cancer	6.34e-07	9.55e-06	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	6.32e-07	9.52e-06	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTEN—hematologic cancer	5.91e-07	8.9e-06	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—EP300—hematologic cancer	5.63e-07	8.48e-06	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—AKT1—hematologic cancer	5.52e-07	8.32e-06	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—AKT1—hematologic cancer	5.21e-07	7.84e-06	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—AKT1—hematologic cancer	5.16e-07	7.77e-06	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.17e-07	6.28e-06	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—AKT1—hematologic cancer	3.4e-07	5.13e-06	CbGpPWpGaD
